Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Petrov I"'
Autor:
Marc A, Pfeffer, Brian, Claggett, Eldrin F, Lewis, Christopher B, Granger, Lars, Køber, Aldo P, Maggioni, Douglas L, Mann, John J V, McMurray, Jean-Lucien, Rouleau, Scott D, Solomon, Philippe G, Steg, Otavio, Berwanger, Maja, Cikes, Carmine G, De Pasquale, Cara, East, Alberto, Fernandez, Karola, Jering, Ulf, Landmesser, Roxana, Mehran, Béla, Merkely, Freny, Vaghaiwalla Mody, Mark C, Petrie, Ivo, Petrov, Morten, Schou, Michele, Senni, David, Sim, Peter, van der Meer, Martin, Lefkowitz, Yinong, Zhou, Jianjian, Gong, Eugene, Braunwald, M, Zughaib
Publikováno v:
New England Journal of Medicine, 385(20), 1845-1855. Massachussetts Medical Society
New England Journal of Medicine, 385(20), 1845-1855. MASSACHUSETTS MEDICAL SOC
for the PARADISE-MI Investigators and Committees 2021, ' Angiotensin receptor–neprilysin inhibition in acute myocardial infarction ', New England Journal of Medicine, vol. 385, no. 20, pp. 1845-1855 . https://doi.org/10.1056/NEJMoa2104508
New England Journal of Medicine, 385(20), 1845-1855. MASSACHUSETTS MEDICAL SOC
for the PARADISE-MI Investigators and Committees 2021, ' Angiotensin receptor–neprilysin inhibition in acute myocardial infarction ', New England Journal of Medicine, vol. 385, no. 20, pp. 1845-1855 . https://doi.org/10.1056/NEJMoa2104508
Sacubitril-Valsartan in Acute Myocardial Infarction In a randomized trial, 5661 patients with acute myocardial infarction and a reduced left ventricular ejection fraction, pulmonary congestion, or both were assigned to receive either sacubitril-valsa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81340cb97426a57d1b6bc014d6d75dab
http://hdl.handle.net/10281/373364
http://hdl.handle.net/10281/373364